DE69936640D1 - Cannabinoiden als antioxidantien und neuroschützende mittel - Google Patents
Cannabinoiden als antioxidantien und neuroschützende mittelInfo
- Publication number
- DE69936640D1 DE69936640D1 DE69936640T DE69936640T DE69936640D1 DE 69936640 D1 DE69936640 D1 DE 69936640D1 DE 69936640 T DE69936640 T DE 69936640T DE 69936640 T DE69936640 T DE 69936640T DE 69936640 D1 DE69936640 D1 DE 69936640D1
- Authority
- DE
- Germany
- Prior art keywords
- cannabinoids
- useful
- found
- disease
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8258998P | 1998-04-21 | 1998-04-21 | |
US9599398P | 1998-08-10 | 1998-08-10 | |
PCT/US1999/008769 WO1999053917A1 (en) | 1998-04-21 | 1999-04-21 | Cannabinoids as antioxidants and neuroprotectants |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69936640D1 true DE69936640D1 (de) | 2007-09-06 |
Family
ID=26767641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69936640T Expired - Lifetime DE69936640D1 (de) | 1998-04-21 | 1999-04-21 | Cannabinoiden als antioxidantien und neuroschützende mittel |
Country Status (8)
Country | Link |
---|---|
US (1) | US6630507B1 (de) |
EP (1) | EP1071419B1 (de) |
JP (1) | JP2002512188A (de) |
AT (1) | ATE367809T1 (de) |
AU (1) | AU766988B2 (de) |
CA (1) | CA2329626A1 (de) |
DE (1) | DE69936640D1 (de) |
WO (1) | WO1999053917A1 (de) |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69936640D1 (de) * | 1998-04-21 | 2007-09-06 | Us Health | Cannabinoiden als antioxidantien und neuroschützende mittel |
US6566560B2 (en) * | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
EP1189603A2 (de) * | 1999-03-22 | 2002-03-27 | Immugen Pharmaceuticals, Inc. | Behandlung von immunerkrankungen wie hiv-erkrankung und neoplastischen erkrankungen |
AU6088200A (en) | 1999-07-12 | 2001-01-30 | Virginia Commonwealth University | Novel vasodilator cannabinoid analogs |
US8449908B2 (en) | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
NZ527289A (en) * | 2001-02-14 | 2005-05-27 | Gw Pharma Ltd | Lipophilic medicaments and their administration via mucosal surfaces |
JP4271445B2 (ja) | 2001-02-16 | 2009-06-03 | アスビオファーマ株式会社 | Aop−1遺伝子又はaop−1の発現減少を伴う疾患の治療方法及び当該疾患治療薬 |
GB2377218A (en) * | 2001-05-04 | 2003-01-08 | Gw Pharmaceuticals Ltd | Process and apparatus for extraction of active substances and enriched extracts from natural products |
WO2003015700A2 (en) * | 2001-08-15 | 2003-02-27 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Novel vasoconstrictor cannabinoid analogs |
US6825209B2 (en) | 2002-04-15 | 2004-11-30 | Research Triangle Institute | Compounds having unique CB1 receptor binding selectivity and methods for their production and use |
WO2003091189A1 (en) * | 2002-04-25 | 2003-11-06 | Virginia Commonwealth University | Cannabinoids |
US20060160776A1 (en) * | 2003-05-28 | 2006-07-20 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a cannabinoid agent for the treatment of central nervous system damage |
IL157849A0 (en) * | 2003-09-10 | 2004-03-28 | Yissum Res Dev Co | Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives |
US20060160748A1 (en) * | 2003-11-25 | 2006-07-20 | Shey-Shing Sheu | Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
IL160420A0 (en) * | 2004-02-16 | 2004-07-25 | Yissum Res Dev Co | Treating or preventing diabetes with cannabidiol |
JP4569142B2 (ja) * | 2004-03-22 | 2010-10-27 | コニカミノルタホールディングス株式会社 | 表示素子 |
US20080262079A1 (en) * | 2004-08-09 | 2008-10-23 | Bernard Mach | Cannabinoid Compositions and Methods of Use Thereof |
EA200701246A1 (ru) * | 2004-12-09 | 2008-06-30 | Инсис Терапьютикс, Инк. | Стабильные при комнатной температуре составы дронабинола |
US7597910B2 (en) * | 2005-08-20 | 2009-10-06 | Slgm Medical Research Institute | Compositions and methods for treating prostate disorders |
ZA200802767B (en) * | 2005-09-29 | 2009-09-30 | Amr Technology Inc | Process for production of delta-9-tetrahydrocannabinol |
EP2007376B1 (de) * | 2006-03-13 | 2013-05-08 | Hadasit Medical Research Services And Development Ltd. | Therapeutische verwendungen von cannabidiol-verbindungen |
NZ573217A (en) | 2006-05-05 | 2011-11-25 | Plascoenergy Ip Holdings S L Bilbao Schaffhausen Branch | A facility for conversion of carbonaceous feedstock into a reformulated syngas containing CO and H2 |
GB2438682A (en) * | 2006-06-01 | 2007-12-05 | Gw Pharma Ltd | New use for cannabinoids |
JP2009539782A (ja) * | 2006-06-08 | 2009-11-19 | ニューロキー エイ/エス | 低体温誘導薬剤の使用方法 |
CA2659775A1 (en) * | 2006-08-04 | 2008-02-14 | Insys Therapeutics Inc. | Aqueous dronabinol formulations |
US9763894B2 (en) * | 2006-12-05 | 2017-09-19 | Virginia Commonwealth University | Inflammation therapy |
WO2008107879A1 (en) * | 2007-03-05 | 2008-09-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Novel cannabidiol derivatives and their use as anti-inflammatory agents |
US8242178B2 (en) * | 2007-06-18 | 2012-08-14 | University Of South Carolina | Use of cannabidiol in the treatment of autoimmune hepatitis |
GB2451254A (en) * | 2007-07-24 | 2009-01-28 | Gw Pharma Ltd | Cannabidiol for use in the treatment of neurodegenerative conditions |
US8293786B2 (en) | 2007-07-30 | 2012-10-23 | Alltranz Inc. | Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
US20090181080A1 (en) * | 2007-08-06 | 2009-07-16 | Insys Therapeutics Inc. | Oral cannabinnoid liquid formulations and methods of treatment |
EP2341903A1 (de) * | 2008-07-31 | 2011-07-13 | Bionorica Research GmbH | Cannabinoide zur behandlung oder prävention von kognitiver beeinträchtigung und demenz |
US10105343B2 (en) | 2010-04-30 | 2018-10-23 | Kubby Patent And Licenses, Limited Liability Company | Cannabis based compositions and methods of treating hypertension |
KR101196354B1 (ko) * | 2010-09-03 | 2012-11-01 | 서유헌 | 퇴행성 신경계 뇌 질환의 예방 또는 치료용 약학 조성물 |
US8642645B2 (en) | 2011-05-20 | 2014-02-04 | Brooks Kelly Research, LLC. | Pharmaceutical composition comprising Cannabinoids |
WO2014100231A1 (en) | 2012-12-18 | 2014-06-26 | Kotzker Consulting Llc | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity |
US10441617B2 (en) | 2013-03-15 | 2019-10-15 | Biotech Institute, Llc | Breeding, production, processing and use of medical cannabis |
WO2014152385A2 (en) | 2013-03-15 | 2014-09-25 | Glia, Llc | Cranial delivery of pharmaceuticals |
MX2015013202A (es) | 2013-03-15 | 2016-04-07 | Biotech Inst Llc | Cultivo, produccion, procesamiento y uso de cannabis de especialidad. |
EP3007714A1 (de) | 2013-06-13 | 2016-04-20 | Cannabis Science International Holding BV | Zusammensetzung zur behandlung von nervenerkrankungen |
CN105764504A (zh) | 2013-09-26 | 2016-07-13 | 罗纳德·D·塞库拉 | 引入大麻种衍生的植物药品的局部治疗 |
PT3552482T (pt) | 2013-10-29 | 2022-09-27 | Biotech Inst Llc | Reprodução, produção, transformação e uso de canábis especial |
US9380813B2 (en) | 2014-02-11 | 2016-07-05 | Timothy McCullough | Drug delivery system and method |
US9220294B2 (en) | 2014-02-11 | 2015-12-29 | Timothy McCullough | Methods and devices using cannabis vapors |
US10821240B2 (en) | 2014-02-11 | 2020-11-03 | Vapor Cartridge Technology Llc | Methods and drug delivery devices using cannabis |
EP3119391A4 (de) | 2014-03-18 | 2017-12-27 | Izun Pharmaceuticals Corp. | Proteingebundene cannabinoidzusammensetzungen |
WO2015200049A1 (en) | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
GB2527599A (en) * | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy |
US9822384B2 (en) | 2014-07-14 | 2017-11-21 | Librede Inc. | Production of cannabinoids in yeast |
US9565865B2 (en) | 2014-08-15 | 2017-02-14 | Imbue LLC | Method for making coffee products containing cannabis ingredients |
US10897915B2 (en) | 2014-08-15 | 2021-01-26 | Blacklist Holdings, Inc. | Method for making coffee products containing cannabis ingredients |
WO2016054268A1 (en) | 2014-09-30 | 2016-04-07 | MJAR Holdings, LLC | Methods of growing cannabaceae plants using artificial lighting |
GB2531282A (en) * | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
CN107205960A (zh) | 2014-10-21 | 2017-09-26 | 联合大麻公司 | 大麻提取物及其制备和使用方法 |
US9539295B2 (en) | 2014-12-05 | 2017-01-10 | Bradley Michael Bohus | Cannabidiol (CBD) enriched alcohol |
US10502750B2 (en) | 2014-12-23 | 2019-12-10 | Biotech Institute, Llc | Reliable and robust method for the analysis of cannabinoids and terpenes in cannabis |
MA41299A (fr) | 2014-12-30 | 2017-11-07 | Axim Biotechnologies Inc | Solutions ophtalmiques pour le traitement du glaucome et de la conjonctivite |
US10830780B2 (en) | 2015-01-26 | 2020-11-10 | Biotech Institute, Llc | Apparatus and methods for sample analysis and classification based on terpenes and cannabinoids in the sample |
US20160298151A1 (en) | 2015-04-09 | 2016-10-13 | Sher Ali Butt | Novel Method for the cheap, efficient, and effective production of pharmaceutical and therapeutic api's intermediates, and final products |
CN107846861A (zh) | 2015-05-28 | 2018-03-27 | 推德有限公司 | Thca合成酶表达改变的大麻植物 |
WO2017066744A1 (en) * | 2015-10-16 | 2017-04-20 | Scythian Biosciences Inc. | Methods and compositions for treating traumatic brain injury |
US20170298399A1 (en) * | 2016-04-15 | 2017-10-19 | Full Spectrum Laboratories Ltd | Biosynthesis of cannabinoid prodrugs and their use as therapeutic agents |
US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
EP3471745A4 (de) | 2016-06-15 | 2020-01-22 | Ojai Energetics PBC | Verfahren und zusammensetzungen zur reduzierung von oxidativem stress |
US20190201350A1 (en) * | 2016-08-15 | 2019-07-04 | Corr-Jensen Inc. | Time release of fat-soluble actives |
WO2018064654A1 (en) * | 2016-10-01 | 2018-04-05 | James Smeeding | Pharmaceutical compositions comprising a statin and a cannabinoid and uses thereof |
WO2018125857A1 (en) | 2016-12-30 | 2018-07-05 | X Traxion, Llc | Extraction of compounds from cannabis |
US10960322B2 (en) | 2018-07-02 | 2021-03-30 | Pratt Bethers | Apparatus for purifying crystals using solvent vapors |
US10308626B1 (en) | 2018-07-02 | 2019-06-04 | Pratt Bethers | Crystal purification in a glass or metal container |
US10561693B2 (en) | 2017-09-01 | 2020-02-18 | MariJ Pharmaceuticals, Inc. | Cultivation, processing, and synthesis of cannabidiols |
EP3453397A1 (de) | 2017-09-12 | 2019-03-13 | Albert Jan Dijkstra | Verfahren zur isolierung eines cannabinoidextrakts und produkt aus cannabispflanzenmaterial |
US10688191B2 (en) | 2018-01-19 | 2020-06-23 | Hr Biomed, Llc | Delivery of a chemotherapy agent across the blood-brain barrier |
CA3110195A1 (en) * | 2018-08-20 | 2020-02-27 | Bessor Pharma, Llc | Process for the production of cannabinoids |
US11026888B1 (en) | 2019-01-04 | 2021-06-08 | Nutrition Therapeutics, Inc. | Functional beverage compositions and methods of using and making same |
US20220106284A1 (en) * | 2019-03-04 | 2022-04-07 | University Of Florida Research Foundation, Inc. | Methods and compositions for substituted axially-chiral cannabinol analogs |
KR20220005066A (ko) | 2019-05-06 | 2022-01-12 | 더 유니버시티 오브 브리티쉬 콜롬비아 | 항생제 칸나비노이드-테르펜 제형 |
WO2021007661A1 (en) * | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
EP4030941A1 (de) | 2019-09-16 | 2022-07-27 | Vapor Cartridge Technology LLC | Arzneimittelverabreichungssystem mit stapelbaren substraten |
GB201916974D0 (en) | 2019-11-21 | 2020-01-08 | Gw Res Ltd | Cannabidol-type cannabinoid compound |
GB201916977D0 (en) | 2019-11-21 | 2020-01-08 | Gw Res Ltd | Cannibidol-type cannabinoid compound |
US11590187B2 (en) * | 2020-01-14 | 2023-02-28 | Shaman Naturals, Llc | Antimicrobial compositions |
CA3074150A1 (en) | 2020-02-18 | 2021-08-18 | Ovation Science, Inc. | Composition and method for transdermal delivery of cannabidiol (cbd) and delta9-tetrahydrocannabinol (thc) |
EP4161900A1 (de) * | 2020-06-03 | 2023-04-12 | Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. | Cannabidiolsäure (cbda)-derivate und verwendungen davon |
GB2597302A (en) * | 2020-07-20 | 2022-01-26 | Gw Res Ltd | Use of cannabidiol in the treatment of seizures associated with stroke or brain haemorrhage |
MX2023001129A (es) | 2020-07-28 | 2023-03-27 | Impello Biosciences Inc | Metodos y composiciones para alterar metabolitos secundarios en plantas. |
US20240116883A1 (en) | 2020-11-24 | 2024-04-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Cannabinoid derivatives and their use the treatment of inflammation and/or pain and/or obesity |
CN112516119A (zh) * | 2021-02-05 | 2021-03-19 | 云南维他源生物科技有限公司 | 一种治疗脑卒中的asbd药物组合物及其制剂与应用 |
TW202311216A (zh) * | 2021-05-12 | 2023-03-16 | 英商吉偉研究有限公司 | 作為醫藥活性化合物之間苯二酚衍生物及其製備方法 |
CA3218225A1 (en) * | 2021-05-12 | 2022-11-17 | GW Research Limited | Rescorcinols, methods for their manufacture, and uses thereof |
WO2023285072A1 (en) | 2021-07-13 | 2023-01-19 | Receptorpharma Inc S-Corp | Esters of 7-cooh cbd derivatives and their use as prevention, prophylaxis of progression, and/or treatment of neurogenerative diseases. |
CN113735709B (zh) * | 2021-09-17 | 2022-03-18 | 中国农业科学院农产品加工研究所 | 一种大麻二酚-2-丁酸酯及其应用 |
CN116253700A (zh) * | 2021-12-10 | 2023-06-13 | 德义制药有限公司 | 一种大麻二酚衍生物及其制备方法和应用 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2304669A (en) | 1940-08-16 | 1942-12-08 | Adams Roger | Isolation of cannabidiol |
US4464378A (en) * | 1981-04-28 | 1984-08-07 | University Of Kentucky Research Foundation | Method of administering narcotic antagonists and analgesics and novel dosage forms containing same |
IL80411A (en) | 1986-10-24 | 1991-08-16 | Raphael Mechoulam | Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them |
US5521215A (en) | 1989-11-07 | 1996-05-28 | Ramot University Authority For Applied Research And Industrial Development Ltd. | NMDA-blocking pharmaceuticals |
US5284867A (en) | 1989-11-07 | 1994-02-08 | Yissum Research Development Company Of The Hebrew University In Jerusalem | NMDA-blocking pharmaceutical compositions |
IL92238A (en) | 1989-11-07 | 1995-07-31 | Yissum Res Dev Co | ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation |
DE69127437T2 (de) | 1990-03-16 | 1998-02-05 | Us Health | Stickoxide zur gewichtsreduktion |
DE4100441A1 (de) | 1991-01-09 | 1992-07-16 | Mack Chem Pharm | Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol |
US5635530A (en) | 1991-09-12 | 1997-06-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them |
US5538993A (en) | 1991-09-12 | 1996-07-23 | Yissum Research Development Company | Certain tetrahydrocannabinol-7-oic acid derivatives |
IL99468A (en) | 1991-09-12 | 1997-09-30 | Yissum Res Dev Co | (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
FR2713225B1 (fr) | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
WO1994012667A1 (en) | 1992-11-27 | 1994-06-09 | The United States Department Of The Army | Inhibitors of arachidonic acid metabolites for preventing neurological damage |
US5696109A (en) | 1992-12-07 | 1997-12-09 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
CA2102142A1 (en) | 1993-03-30 | 1994-10-01 | Andrew J. Ghio | Method of inhibiting oxidants using alkylaryl polyether alcohol polymers |
FR2714057B1 (fr) | 1993-12-17 | 1996-03-08 | Sanofi Elf | Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant. |
US5434295A (en) * | 1994-02-07 | 1995-07-18 | Yissum Research Development Company | Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds |
ZA958725B (en) | 1994-10-20 | 1997-04-16 | Lilly Co Eli | Treatment of disorders with duloxetine |
IT1271267B (it) | 1994-12-14 | 1997-05-27 | Valle Francesco Della | Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi |
FR2741621B1 (fr) | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
GB9807639D0 (en) | 1998-04-14 | 1998-06-10 | Kennedy Rheumatology Inst | Anti-inflammatory agents |
DE69936640D1 (de) * | 1998-04-21 | 2007-09-06 | Us Health | Cannabinoiden als antioxidantien und neuroschützende mittel |
-
1999
- 1999-04-21 DE DE69936640T patent/DE69936640D1/de not_active Expired - Lifetime
- 1999-04-21 AU AU38646/99A patent/AU766988B2/en not_active Expired
- 1999-04-21 EP EP99921427A patent/EP1071419B1/de not_active Expired - Lifetime
- 1999-04-21 AT AT99921427T patent/ATE367809T1/de not_active IP Right Cessation
- 1999-04-21 WO PCT/US1999/008769 patent/WO1999053917A1/en active IP Right Grant
- 1999-04-21 CA CA002329626A patent/CA2329626A1/en not_active Abandoned
- 1999-04-21 JP JP2000544322A patent/JP2002512188A/ja active Pending
- 1999-04-21 US US09/674,028 patent/US6630507B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1071419A1 (de) | 2001-01-31 |
CA2329626A1 (en) | 1999-10-28 |
ATE367809T1 (de) | 2007-08-15 |
WO1999053917A1 (en) | 1999-10-28 |
JP2002512188A (ja) | 2002-04-23 |
AU766988B2 (en) | 2003-10-30 |
EP1071419B1 (de) | 2007-07-25 |
AU3864699A (en) | 1999-11-08 |
US6630507B1 (en) | 2003-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE367809T1 (de) | Cannabinoiden als antioxidantien und neuroschützende mittel | |
HRP20050735A2 (en) | Dihydropteridinones, method for the production and use thereof in the form of drugs | |
MY133406A (en) | 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as a medicament | |
AR029383A1 (es) | Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes | |
AP1422A (en) | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent. | |
EE200100317A (et) | Uued bifenüül- ja bifenüülanaloogsed ühendid kui integriini antagonistid | |
AR029634A1 (es) | Compuestos derivados heterociclicos utiles como agentes anticancerosos, composicion farmaceutica y procedimiento de tratamiento | |
YU4397A (sh) | Novi supstituisani oksazolidinoni | |
DE69908819D1 (de) | Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten | |
BG105513A (en) | Substituted benzopyran analogs for the treatment of inflammation | |
HUP0400998A2 (hu) | Új gyulladásgátló, immunmodulátor és antiproliferatív hatású vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
MXPA05012840A (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades. | |
IL123002A0 (en) | 1-Phenyl-2- phenylacetoxy- ethanone derivatives | |
ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
IL162214A (en) | Pyridine derivatives and pharmaceutical compositions containing the same | |
ATE411296T1 (de) | Imidazolinderivate mit cb1-antagonistischer wirkung | |
TW200505862A (en) | 2-amino-pyridine derivatives useful for the treatment of diseases | |
MXPA04000814A (es) | Derivados de 2h-piridazina-3-ona novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento para la preparacion del ingrediente activo. | |
ATE364043T1 (de) | Pyrazolo-pyridine für die behandlung von herpes- ansteckungen | |
ES2168304T3 (es) | Derivados del taxol. | |
ES2243579T3 (es) | Derivados de pirazolopirideno. | |
TW200505865A (en) | Compounds useful for the treatment of diseases | |
TW200510365A (en) | Benzopyran compounds useful for treating inflammatory conditions | |
EE200200466A (et) | 8,8a-dihürdroindeno[1,2-d]tiasooli derivaadid, mis on asendatud 8a-asendis, nende valmistamismeetodja kasutamine ravimitena, näiteks anorektiliste toimeainetena | |
ES2036926A1 (es) | "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina". |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |